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Abstract
Holoprosencephaly (HPE) is a severe human genetic disease affecting craniofacial development, with an incidence of up to
1/250 human conceptions and 1.3 per 10,000 live births. Mutations in the Sonic Hedgehog (SHH) gene result in HPE in
humans and mice, and the Shh pathway is targeted by other mutations that cause HPE. However, at least 12 loci are
associated with HPE in humans, suggesting that defects in other pathways contribute to this disease. Although the TGIF1
(TG-interacting factor) gene maps to the HPE4 locus, and heterozygous loss of function TGIF1 mutations are associated with
HPE, mouse models have not yet explained how loss of Tgif1 causes HPE. Using a conditional Tgif1 allele, we show that
mouse embryos lacking both Tgif1 and the related Tgif2 have HPE-like phenotypes reminiscent of Shh null embryos. Eye and
nasal field separation is defective, and forebrain patterning is disrupted in embryos lacking both Tgifs. Early anterior
patterning is relatively normal, but expression of Shh is reduced in the forebrain, and Gli3 expression is up-regulated
throughout the neural tube. Gli3 acts primarily as an antagonist of Shh function, and the introduction of a heterozygous Gli3
mutation into embryos lacking both Tgif genes partially rescues Shh signaling, nasal field separation, and HPE. Tgif1 and
Tgif2 are transcriptional repressors that limit Transforming Growth Factor b/Nodal signaling, and we show that reducing
Nodal signaling in embryos lacking both Tgifs reduces the severity of HPE and partially restores the output of Shh signaling.
Together, these results support a model in which Tgif function limits Nodal signaling to maintain the appropriate output of
the Shh pathway in the forebrain. These data show for the first time that Tgif1 mutation in mouse contributes to HPE
pathogenesis and provide evidence that this is due to disruption of the Shh pathway.
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Introduction
Holoprosencephaly (HPE) is a prevalent human disorder
affecting forebrain and craniofacial development, with an
incidence of up to 1:250 during embryogenesis, and a high
frequency of intrauterine lethality [1,2]. Recent estimates of the
frequency of HPE live births are as high as 1.3 per 10,000 [3], and
many children born with severe HPE phenotypes die soon after
birth [4,5]. The primary defect in HPE is a failure of ventral
forebrain development with concomitant defects in midline facial
structures [6,7]. In its most severe form (alobar HPE) the forebrain
fails to divide, resulting in a single brain ventricle. Less devastating
forms of HPE allow near or complete separation of left and right
hemispheres [8,9]. At least 12 genetic loci have been implicated in
HPE by mapping of the minimal chromosomal regions deleted in
affected families [10–12]. Perhaps the best studied HPE gene, Sonic
hedgehog (SHH), maps to the HPE3 locus [13]. In humans
heterozygous SHH loss of function mutations account for 17%
of familial HPE and 3.7% of sporadic cases [13–15], suggesting a
loss of function haploinsufficient phenotype [16,17]. The genes
encoding the transcription factors TGIF1, Six3 and Zic2 have
been identified as the affected genes at other HPE loci [18–20].
Interestingly, recent work has shown that Six3 specifically activates
expression of Shh in the forebrain, and in mice Shh and Six3
mutations synergize to cause HPE, further emphasizing the
importance of the Shh pathway [21,22].
To establish forebrain dorsoventral patterning, the proper
output of the Shh signaling pathway is essential in prechordal plate
(PrCP), a primitive streak-derived axial tissue. In mouse embryos
at 7.75 dpc, Shh expression is seen in the PrCP underlying the
forebrain precursor tissue. Shh expression in the PrCP is essential
for activating Shh expression in the overlying ventral diencephalon
tissue by 9.0 dpc, where Shh specifies ventral identity [1,23]. Gli3,
a zinc-finger transcription factor that primarily acts as a repressor
of Shh signaling, has been shown to play a crucial role in forebrain
dorsoventral patterning. In the developing neural tissue, Gli3 is
expressed in a gradient that is higher dorsally, and Gli3
homozygous null embryos have a forebrain with dorsally
expanded ventral tissue, that lacks dorsal identity [24–26]. It has
been shown that the proper balance between Gli3 and the
ventralizing Shh is critical during forebrain patterning [25,27].
The lack of ventral identity seen in Shh null embryos is partially
rescued when the dose of Gli3 is reduced genetically, suggesting
that the mutual antagonism of these two factors is critical for
forebrain dorso-ventral patterning. However, since the forebrain
develops relatively normally in the absence of both Shh and Gli3,
there must be additional pathways that specify telencephalon
development, which likely depend on Foxg1 and FGF signaling
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Fgfr1 and Fgfr2 genes results in defective ventral telencephalon
development, without disruption of the Shh signaling pathway
[29].
TGIF1 (Thymine/Guanine-Interacting Factor) is a homeodo-
main protein, which binds directly to DNA via a thymine/
guanine-containing consensus site, or interacts with Transforming
Growth Factor (TGF) b-activated Smad proteins [30,31]. In
response to binding of a TGFb family ligand to its receptors, the
receptor complex phosphorylates and activates specific receptor
Smad (R-Smad) proteins: Smad2 or Smad3 in the case of TGFb,
Nodal and Activin [32,33]. Activated R-Smads complex with the
co-Smad, Smad4, translocate to the nucleus and activate target
gene expression via direct binding to DNA, or by interactions with
other sequence specific DNA binding proteins [33]. Once
recruited to DNA, a Smad complex activates transcription in part
through interactions with general coactivators, such as p300/CBP
[33]. The presence of specific Smad transcriptional corepressors,
such as TGIF1, limits the transcriptional response by competing
with coactivators and by recruiting general corepressor complexes
to the Smads [31,34]. The more recently identified TGIF2 is
homologous to TGIF1 and functions similarly. TGIF2 interacts
directly with DNA, or with TGFb activated Smads and represses
gene expression via the mSin3/HDAC complex, but unlike
TGIF1, it does not interact with CtBP corepressors [35–37]. Thus
overall Tgif function (TGIF1 and TGIF2) limits the magnitude of
the transcriptional response to TGFb family ligands. In addition to
regulating TGFb signaling, TGIF1 can also repress gene
expression via the RXR retinoid receptor [30,38,39].
The TGIF1 gene lies within the minimal HPE4 locus, and
TGIF1 sequences were shown to be absent from individuals
affected with HPE [20]. In addition to the more common deletions
of TGIF1, single amino acid miss-sense mutations have been
identified, some of which reduce transcriptional repression by
TGIF1 [20,40–42]. Heterozygous loss of TGIF1 causes HPE in
humans, suggesting a haploinsufficient phenotype [20]. While
there is no evidence for mutations in the human TGIF2 gene being
associated with HPE, it is clearly possible that these two related
proteins share overlapping functions during embryogenesis [42].
In mice, loss of Tgif1 does not have severe phenotypic
consequences, at least in a mixed strain background [38,43–45].
In a more pure C57BL/6 strain background placental defects and
reduced viability are associated with loss of Tgif1, and an
intragenic mutation in Tgif1 that may result in expression of a
truncated polypeptide caused some anterior defects [46,47]. As
with Tgif1, Tgif2 null mice are normal on a mixed strain
background, but the combination of both mutations results in
early embryonic lethality with gastrulation defects in all embryos
that are homozygous null for both genes [48]. Genetically
reducing Nodal signaling in these embryos reduces the severity
of the gastrulation defects, consistent with an inhibitory role for
Tgifs in the TGFb/Nodal pathway. While this demonstrates an
essential role for TGIF function early in embryogenesis, the
function of Tgifs after gastrulation is less well understood.
Here, we investigated the role of Tgif1 and Tgif2 during
forebrain development. We demonstrate that loss of Tgif function
is indeed important in HPE pathogenesis, and that Tgif1 and
Tgif2 play overlapping essential roles during ventral forebrain
development by regulating Shh signaling. Conditional loss of
function of Tgif1 in the background of a Tgif2 null mutation causes
HPE. Furthermore, we show that the HPE phenotype is partially
rescued when the dose of Gli3 is reduced. Additionally, we show
that reducing Nodal signaling reduces the severity of the HPE
phenotype, and partially restores the output of the Shh pathway.
This provides the first evidence that Tgifs are required for proper
Shh signaling during ventral forebrain development, and verifies
that TGIF1 is a bona fide HPE gene.
Results
Loss of Tgif1 and Tgif2 causes HPE
We have previously shown that loss of both Tgif1 and Tgif2
results in a failure of gastrulation [48]. Conditional deletion of
Tgif1 in the epiblast, using a loxP flanked Tgif1 allele [45] and the
Sox2-Cre transgene, which is expressed in the epiblast after 5.5 dpc
[49], in the background of a Tgif2 null mutation allows these
embryos (which we refer to as cdKO, for conditional double
knock-out) to complete gastrulation. However, most cdKO
embryos do not survive past 11.0 dpc, have left-right asymmetry
defects, and have severe anterior defects. Scanning electron
microscopy (SEM) analysis of frontal forebrain structure revealed
that the ventral lips of the cephalic folds are fused in cdKO
embryos at 8.25 dpc, as seen in Shh null embryos (asterisks,
Figure 1A). It has been shown previously that the normally
separated cephalic neural tube is fused in mouse mutants with
HPE, including Shh null embryos [50,51]. Additional SEM
analysis at later stages shows that the midbrain neural tube fails
to close in cdKO embryos even at 9.25 dpc (Figure 1B). Since
human TGIF1 mutations are associated with HPE, we next
analyzed the forebrain morphology of control and cdKO embryos
to determine whether there was additional morphological evidence
to suggest that cdKO embryos have HPE. Whole-mount
morphology of the cdKO forebrain at 9.0 dpc showed that overall
forebrain size and morphology were relatively normal compared
to the control. H&E staining showed that neuroepithelium and
surface ectoderm were present, but that the neuroepithelium is
thinner and lacks any indication of ventral morphology of the
control (Figure 1C). By 10.0 dpc the cdKO forebrain was clearly
abnormal, and was significantly smaller than the control
(Figure 1D). Further analysis of forebrain structure by H&E
staining showed that ventral forebrain morphology was defective,
and that cdKO embryos appeared to have a single thickened layer
of surface ectoderm in the ventral forebrain, suggesting that the
Author Summary
Holoprosencephaly (HPE) is a devastating genetic disease
affecting human brain development. HPE affects more
than 1/8,000 live births and up to 1/250 conceptions.
Several genetic loci are associated with HPE, and the
mutated genes have been identified at some. We have
analyzed the role of the TGIF1 gene, which is present at
one of these loci (the HPE4 locus) and is mutated in a
subset of human HPE patients. We show that Tgif1
mutations in mice cause HPE when combined with a
mutation in the closely related Tgif2 gene. This provides
the first evidence from model organisms that TGIF1 is in
fact the gene at the HPE4 locus that causes HPE when
mutated. The Sonic Hedgehog signaling pathway is the
best understood pathway in the pathogenesis of HPE, and
mutation of the Sonic Hedgehog gene in both humans and
mice causes HPE. We show that mutations in Tgif1 and
Tgif2 in mice cause HPE by disrupting the Sonic Hedgehog
signaling pathway, further emphasizing the importance of
this pathway for normal brain development. Thus we
confirm TGIF1 as an HPE gene and provide genetic
evidence that Tgif1 mutations cause HPE by disrupting
the interplay of the Nodal and Sonic Hedgehog pathways.
Tgif and Holoprosencephaly
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HPE phenotypes, such as cyclopia, are more apparent after
11.0 dpc, we analyzed a large number of embryos at 12.5 dpc in
an attempt to identify any cdKO embryos that survive to this stage.
Although the most of the cdKO embryos die by 11.0 dpc, we were
able to identify two cdKO embryos that had survived to 12.5 dpc.
For this analysis, we dissected a total of 117 embryos at 12.5 dpc, 76
(65%) of which appeared normal, 39 (33%) were in the process of
being resorbed, and only two were doubly homozygous null for
Tgif1 and Tgif2. Both cdKO embryos showed cyclopia, and one of
Figure 1. Analysis of the HPE phenotype in cdKO embryos. (A) Scanning electron microscopy (SEM) images of the frontal anterior view of
embryos at 8.25 dpc, from Tgif1;Tgif2 conditional double intercrosses with epiblast specific deletion of the conditional Tgif1 allele (referred to as
cdKO), Shh mutant intercrosses and a stage matched control are shown. The genotype of the control embryos is not indicated as they are
representative of normal embryos from these crosses. The arrow indicates the separation of ventral lips of the cephalic folds in the control, that is
defective in the cdKO and Shh null (marked by asterisks). Note, the conditional Shh null allele is referred to as ‘r’, for recombined. (B) SEM images of
the frontal view of the forebrain of control and cdKO embryos at 8.75 and 9.25 dpc are shown. (C and D) Whole-mount images and hematoxylin and
eosin (H&E) stained coronal section of fixed and paraffin-embedded control and cdKO embryos at 9.0 (C) and control, cdKO and Shh
r/r at 10.0 dpc (D).
The white lines indicate the plane of the coronal sections through the forebrain vesicle. Embryos are representative of at least 3 analyzed. In D, the
division of the nasal field by the neuroepithelium is marked by an arrow. Note the continuous thickened layer of surface ectoderm in the mutants. (E)
Whole mount images and H&E stained sections of fixed and paraffin-embedded control, cdKO and Shh null embryos at 12.5 dpc are shown. The two
planes of section are indicated in the upper panels, and a magnified view of the eye is shown at the bottom (boxed region in section ii). Only two
cdKO embryos were identified at this stage. Scale bars: 100 mm in A and B; 250 mm for whole-mount and 100 mm for section in C; 500 mm for whole-
mount and 200 mm for sections in D; 2 mm for whole-mount, 250 mm for i, 500 mm for ii and 100 mm for ii-zoom in E.
doi:10.1371/journal.pgen.1002524.g001
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stage Shh null embryo (Figure 1E). H&E staining of coronal sections
through the brain tissue clearly showed that only one nasal
epithelium structure was present in the proboscis tissue of both
cdKO and Shh null embryos (Figure 1E, i), and that only one eye
field was present in cdKO and Shh null embryos (Figure 1, ii). Thus,
the morphological abnormalities in the cdKO forebrain appeared
to be quite similar to those seen in Shh null embryos, suggesting that
cdKO embryos exhibit a classic form of HPE.
Anterior patterning in cdKO embryos
The defects in forebrain structure led us to test whether anterior
patterning is defective in cdKO embryos. The expression of Six3,a
transcription factor that activates the Shh gene in ventral forebrain
[21,22], was seen in forebrain in both control and cdKO embryos
(Figure 2A). Foxg1, a transcription factor that is required for proper
forebrain patterning [52], is expressed in approximately the
appropriate pattern in cdKO embryos (Figure 2A). Although there
was no major change in the expression pattern, the expression
levels of Six3 and Foxg1 were slightly increased in cdKO embryos.
In addition, the expression of Fgf8 was clearly increased in the
cdKO forebrain, but was still present in approximately the same
region as in control embryos (Figure 2A). Consistent with these
observations, Fgf8 has been shown to be a FoxH1/Smad2 target
gene in the anterior, so may be up-regulated in the absence of
Tgifs due to derepression of Smad dependent transcription [53].
Hesx1, which is a highly specific marker for ventral diencephalon
[54], shows the appropriate expression pattern in the cdKO
ventral diencephalon tissue at 9.0 dpc, suggesting that the midline
of the ventral diencephalon is formed in cdKO embryos
(Figure 2B). Emx2, a transcription factor that is required for dorsal
forebrain patterning [55], was slightly decreased, but was present
in a similar domain as in the control (Figure 2B). We next analyzed
prospective forebrain tissue in younger embryos. At 7.25 dpc
Hesx1 was expressed in the anterior of both control and cdKO
embryos (Figure 2C). We have shown previously that the forebrain
marker, Otx2, was expressed in cdKO embryos at 7.5 dpc [48],
and Six3 was also expressed in the prospective forebrain tissue of
cdKO embryos at early head fold (EHF) stage (Figure 2C). Taken
together these results suggest that forebrain tissue is for the most
part correctly patterned in cdKO embryos.
In the mouse, forebrain induction and patterning is mediated by
primitive streak-derived anterior midline tissue, which includes
anterior definitive endoderm (ADE) and PrCP [23,56]. At
7.25 dpc the expression of Hex, a transcription factor that is
essential for endoderm development [57], was seen in both control
and cdKO embryos in anterior visceral endoderm and also in the
ADE migrating out of the primitive streak at this stage (Figure 2D).
By 7.5 dpc, Hex expression in anteriorly migrated ADE tissue was
present, and did not appear to be significantly different between
control and cdKO embryos (Figure 2D). A member of the
Forkhead transcription factor family, Foxa2, which is normally
expressed in axial tissue [58], was expressed in midline tissue of
cdKO embryos at the EHF stage (Figure 2E). The PrCP can be
identified by expression of Gsc and Dkk1 at late head fold (LHF)
stage and at 8.0 dpc [56,59]. Appropriate expression of both Gsc
and Dkk1 was seen in cdKO embryos (Figure 2E and [48]),
suggesting that the PrCP is present in the absence of Tgifs. This
analysis suggests that anterior structures are initially patterned
relatively normally in cdKO embryos.
Figure 2. Analysis of anterior patterning in cdKO embryos. Stage matched control and cdKO embryos were analyzed by in situ hybridization
with anti-sense probes for Six3, Foxg1 and Fgf8 at 9.0 dpc (A), Hesx1 and Emx2 at 9.0 dpc (B) and Hesx1 and Six3 at 7.25 and 7.5 dpc respectively (C).
Stage matched control and cdKO embryos were analyzed at the indicated stages by in situ hybridization for Hex (D), and Foxa2 and Dkk1 (E). Images
shown are representative of at least 3 embryos each. Scale bars: 125 mm in A, B, C and D; 250 mmi nE .
doi:10.1371/journal.pgen.1002524.g002
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While there are clearly some phenotypic differences, such as
the failure of the midbrain to close in cdKO embryos, the
similarities between cdKO and Shh null embryos raised the
possibility that HPE in cdKO embryos may be due to defects in
the Shh signaling pathway. At 9.5 dpc, Shh was expressed
throughout the neural tube in the floor plate, including the
midline of the ventral diencephalon of control embryos
(Figure 3A). However, Shh expression was clearly reduced in
the ventral diencephalon of cdKO embryos. Similarly, in cdKO
embryos Shh expression was reduced in the anterior midline at
8.25 dpc (Figure 3B). By 8.75 dpc Shh expression was present in
the ventral forebrain in the control, whereas expression was
clearly reduced in the cdKO ventral forebrain tissue (Figure 3B).
Transverse sections showed that Shh expression is present but is
reduced in the midline tissue including the PrCP (arrows,
Figure 3B), and that Shh expression is not detected in the ventral
forebrain (Figure 3B). We next analyzed the expression pattern of
Shh signaling components at 9.0 dpc. Ptch1 encodes a 12
transmembrane Shh receptor, and Gli1, a transcription factor
that mediates Shh signaling [60]. Both genes are direct
downstream targets of Shh signaling and are normally expressed
strongly in the ventral diencephalon. In cdKO embryos the
expression of Gli1 was clearly reduced primarily in the ventral
forebrain, while expression was more normal throughout the
neural tube up to the forebrain-midbrain boundary (Figure 3C).
Ptch1 expression was more similar between cdKO and control
embryos, although there was a slight decrease in expression in
the anterior in cdKO embryos (brackets, Figure 3C). Together,
these results suggest that forebrain patterning is relatively
normal, but that the Shh signaling pathway is defective
specifically in the ventral forebrain and PrCP. Thus it appears
that Tgif function may be required for normal Shh signaling in
anterior tissues.
Shh signaling is rescued by a reduction in Gli3 levels
The transcription factor, Gli3, acts as a potent repressor of the
Shh signaling pathway. In the absence of Shh, it has been shown
that there is some increase in Gli3 expression [24], and the HPE
phenotype in Shh null embryos is partially rescued when Gli3 gene
dosage is reduced, suggesting that the proper balance of
dorsalizing and ventralizing signals is critical during forebrain
development [27,61]. We, therefore, analyzed the expression level
of Gli3 in control and cdKO embryos. Strikingly, Gli3 expression
was clearly increased throughout the neural tube including the
forebrain in cdKO embryos (Figure 4A). We also performed
WISH for Gli3 in Shh null embryos and compared the level of Gli3
expression with cdKO embryos. Surprisingly, Gli3 expression was
higher in cdKO embryos than in Shh null embryos (Figure 4A),
suggesting that there may be an additional Tgif-mediated
mechanism, distinct from the reduction in Shh expression, that
regulates Gli3 expression.
To determine whether the increased level of Gli3 contributes to
defective Shh signaling in the absence of Tgif function, we
performed a genetic rescue experiment by introducing a Gli3
mutant allele into the cdKO background. The Gli3 allele has exon
8 flanked by loxP sites such that Cre-mediated recombination
creates a null allele [62], which is referred to here as Gli3
r.I n
Gli3
+/r;cdKO embryos, Gli3 expression was significantly reduced,
to below the expression level seen in Shh null embryos (Figure 4A).
In contrast, Shh expression was not restored in cdKO embryos that
were heterozygous for Gli3, or in cdKO embryos that were
homozygous null for the Gli3 gene (Gli3
r/r;cdKO), suggesting that
the reduction in Shh expression is at least partially independent of
Gli3 activity in cdKO embryos (Figure 4B). We then analyzed the
expression of Nkx2.1, a downstream target gene of Shh signaling in
the forebrain [1,23], in control and a series of mutant embryos. At
9.0 dpc, the expression of Nkx2.1 was seen in the ventral
diencephalon in control embryos, whereas, Nkx2.1 expression
Figure 3. Defective Shh signaling in the forebrain of cdKO embryos. (A and B) Stage matched control and cdKO embryos at the indicated
ages were analyzed by in situ hybridization for Shh. Whole mount and images of coronal sections through the forebrain vesicle of paraffin-embedded
control and cdKO embryos at 9.5 dpc (A) and transverse sections through ventral forebrain and neural tube at 8.75 dpc (B) are shown. The arrows in B
indicate the Shh expression in midline tissue. (C) Stage matched control and cdKO embryos at 9.0 dpc were analyzed by in situ hybridization for Gli1
and Ptch1. Brackets in C indicate the expression domain that is reduced in the cdKO. White lines indicate the plane of sections. Images shown are
representative of at least 3 embryos. Scale bars: 250 mm for whole-mount and 100 mm for sections in A; 125 mm for whole-mount and 100 mm for
sections in B; 250 mmi nC .
doi:10.1371/journal.pgen.1002524.g003
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Gli3
+/r;cdKO embryos, Nkx2.1 expression was clearly restored
while Nkx2.1 expression in the ventral diencephalon was not
rescued in Gli3
+/r;Shh
r/r embryos (Figure 4C). These results suggest
that a reduction in the excess Gli3 expression partially restores the
output of the Shh signaling pathway in cdKO embryos, without
affecting Shh expression itself.
Reduced Gli3 levels rescue cdKO ventral forebrain
morphology
Initial observation of Gli3 heterozygous cdKO embryos suggests
that there may be some phenotypic rescue of the cdKO
phenotype. Instead of the round forebrain morphology seen in
cdKO embryos, a more structured forebrain vesicle was observed
in Gli3
+/r;cdKO embryos at 10.0 dpc (Figure 5A). To further
determine the degree of phenotypic rescue, we H&E stained
coronal sections through the forebrain vesicle of control, cdKO
and Gli3 heterozygous cdKO embryos. Gli3
+/r;cdKO embryos
clearly had a more organized forebrain neuroepithelium mor-
phology, and the neuroepithelium appeared to have initiated
division of the nasal placode (arrows, Figure 5A), suggesting that
the altered balance between Gli3 and Shh expression in cdKO
embryos does contribute to the HPE phenotype. In addition, SEM
analysis of Gli3 heterozygous cdKO embryos at 8.25 dpc shows a
partial rescue of the forebrain structure, such that the Gli3
heterozygous forebrain appears to be less disorganized than the
cdKO, and the ventral lips of the cephalic folds appear to be
partially separated in the Gli3
+/r;cdKO (arrows, Figure 5B). Thus,
it appears that reducing Gli3 levels results in some rescue of the
cdKO phenotype. To address this further, we tested for changes in
proliferation and examined forebrain patterning.
Since the anterior of the cdKO is clearly reduced in size by
10.0 dpc, we tested whether the apparent morphological rescue by
Gli3 heterozygosity might be due to a restoration of proliferation.
Antibody staining for cleaved caspase 3, which is a marker of
apoptotic cells, identified very few apoptotic cells in either control
or cdKO forebrain at 9.0 dpc (Figure 5C). Although the cdKO
embryos were still alive at 10.0 dpc, cells that were positive for
cleaved caspase were present throughout the cdKO forebrain
neuroepithelium, but were rarely seen in the control (Figure 5C).
Figure 4. Rescue of Shh signaling by a reduction in Gli3 levels. (A) Stage matched control, cdKO, Gli3
+/r;cdKO and Shh
r/r embryos at 9.0 dpc
were analyzed by in situ hybridization for Gli3. (B) Stage matched control, cdKO, Gli3
+/r;cdKO and Gli3
r/r;cdKO embryos at 9.0 dpc were analyzed by in




r/r embryos at 9.0 dpc were analyzed by in situ
hybridization for Nkx2.1. Whole mount and coronal sections through the rostral (i) and caudal (ii) forebrain are shown. The white lines indicate the
planes of the sections. Embryos shown are representative of at least 3. Scale bars: 250 mm for whole-mount and 50 mm for sections.
doi:10.1371/journal.pgen.1002524.g004
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in the cdKO forebrain at 10.0 dpc (Figure 5C). To determine
whether proliferation is reduced in cdKO embryos, we stained
multiple coronal sections of control and cdKO forebrains at 9.0
and 10.0 dpc with an antibody to Histone H3, phosphorylated on
serine 10 (pHH3), which is a marker for cells in late G2 and
mitosis. Mitotic cells were seen throughout neuroepithelium for
both control and cdKO at 9.0 dpc (Figure 5D). Quantification of
the proportion of mitotic cells in the neuroepithelium showed that
there was a significant reduction in proliferation at 9.0 dpc, that
was more pronounced by 10.0 dpc (Figure 5E and 5F). These
results suggest that cdKO embryos have proliferation defects in
the forebrain neuroepithelium, and that the reduced proliferation
is seen prior to any increase in apoptosis. We next tested whether
the apparent rescue of forebrain morphology in Gli3
+/r;cdKO
embryos was accompanied by a restoration of normal levels of
proliferation. However, in Gli3
+/r;cdKO embryos, proliferation
levels were not different from the cdKO at 10.0 dpc (Figure 5E
and 5F). This suggests that the phenotypic rescue in Gli3
+/r;cdKO
embryos is independent of changes in proliferation, and that the
morphological defects in the cdKO are not solely due to reduced
proliferation.
To further characterize ventral structure, we analyzed the
expression pattern of Pax7, a nasal field marker, as well as the eye
field marker, Pax2 [61]. Normally by 10.0 dpc, the nasal field is
well separated as evidenced by the position of the ventral
Figure 5. Rescued ventral forebrain structure in Gli3 mutant cdKO embryos. (A) Whole-mount images and H&E stained coronal sections
through the forebrain vesicle of control, cdKO and Gli3
+/r;cdKO embryos at 10.0 dpc are shown. The white lines indicate the plane of coronal sections.
Arrows indicate the division of the nasal field by the neuroepithelium. (B) SEM images of frontal anterior view of control, cdKO and Gli3
+/r;cdKO are
shown at 8.25 dpc. The arrows indicate the separation of the ventral lips of the cephalic folds in the control, and the partial rescue of this morphology
in the Gli3
+/r;cdKO, compared to the complete failure in the cdKO (asterisk). (C) Coronal sections of control and cdKO embryos at 9.0 and 10.0 dpc
were analyzed by IHC with antibodies for cleaved caspase 3, or by TUNEL at 10.0 dpc. (D) Coronal sections of control and cdKO embryos at 9.0 dpc
were analyzed by IHC with antibodies for Histone H3, phosphorylated on serine 10 (pHH3). (E) Coronal sections of control, cdKO and Gli3
+/r;cdKO
embryos were analyzed by IHC for pHH3 (F) The mitotic index of the forebrain neuroepithelium of control and cdKO embryos at 9.0 or 10.0 dpc, and
of Gli3
+/r;cdKO at 10.0 dpc was calculated for each section as the percentage of pHH3-stained nuclei. This data is from four control and five cdKO
embryos at 9.0 dpc, and three embryos each at 10.0 dpc. Average+s.d. is shown, with the statistical significance as calculated by Student’s t-test.
Embryos are representative of at least 3 analyzed, unless otherwise noted. Scale bars: 50 mm for sections of 9.0 dpc embryos; 100 mm for sections
from 10.0 dpc embryos.
doi:10.1371/journal.pgen.1002524.g005
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example). In Shh null embryos, Pax7 expression is present in a single
central region suggesting that the nasal field is not fully separated,
whereas when the dose of Gli3 is reduced in Shh null embryos Pax7
expression becomes separated to the two nasal fields [61]. In cdKO
embryos, Pax7 expression was observed as a single continuous band,
suggesting that nasal field separation is defective (Figure 6A). In
Gli3
+/r;cdKO embryos, Pax7 expression was clearly well separated
and was more similar to that seen in controls, suggesting that the
nasal field separation defect is partially rescued in Gli3 heterozygous
cdKO embryos (Figure 6A). Similarly, Pax2 expression was reduced
and was seen as a single continuous band in cdKO embryos,
suggesting that eye field separation is defective (Figure 6B). In Gli3
+/r;
cdKO embryos, the Pax2 expression level was increased, and
appeared as less of a continuous band with distinct eye fields on both
sides of the forebrain (Figure 6B). These results suggest that the
increase in Gli3 expression, and the altered balance between Gli3and
Shh contribute to the HPE phenotype seen in cdKO embryos
resulting in a disruption of the separation of facial primordia.
Nodal dependence of forebrain development in the
cdKO embryos
The TGFb/Nodal signaling pathway has been linked to HPE
pathogenesis. For example, HPE has been reported in mouse
mutants that result in reduced TGFb/Nodal signaling, such as
Nodal;Smad2 double heterozygotes [63]. Since mutations in these
genes result in a reduction in the output of TGFb/Nodal signaling,
rather than the expected increase in cdKO embryos, we generated
mice that are heterozygous for both Nodal and Smad2 genes for
comparison to our cdKOs. The Smad2 null allele is referred to here
as ‘r’ and the Nodal null allele as ‘z’ (see Materials and Methods for a
full explanation). Of 41 Nodal;Smad2 double heterozygotes analyzed
between 10.5 and 12.5 dpc only one had HPE, although an
additional 15 of the 41 double heterozygotes had anterior
truncations or a severe growth delay. The Nodal;Smad2 double
heterozygous embryo with HPE had a proboscis and a partial
failure to separate the eyes, but was significantly larger than cdKO
and Shh null embryos (Figure S1). H&E staining of sections through
the nasal structure showed a single nasal epithelium that appears
structurally similar to that of cdKO and Shh null embryos (Figure
S1, i). H&E staining of sections through the eye field showed that a
laterally elongated, large optic structure containing two distinct eyes
had begun to form, while cdKO and Shh null embryos had only one
small pigmented eye field vesicle (Figure S1, ii). Thus, in contrast to
the cdKO embryos, it appears that in embryos with reduced Nodal
pathway activity HPE is relatively rare.
Our previous analysis of Tgif1;Tgif2 double null mutants showed
that Tgifs limit Nodal signaling [48]. To test whether the HPE
phenotypes in cdKO embryos were due to increased Nodal
signaling, we generated cdKO embryos that carry a Nodal
heterozygous mutation. Initial examination of the Nodal heterozy-
gous cdKO embryos suggests that there may be some rescue of the
HPE phenotype (Figure 7A). From 317 embryos dissected at
10.0 dpc we identified 38 Nodal heterozygous cdKO embryos,
representing 12% of the total, which compares well to the
expected 12.5% from these crosses. Other than two severely
delayed embryos, and a small proportion (less than 10%) that had
severe anterior truncations, the Nodal heterozygous cdKO embryos
could be divided into two main phenotypic classes. Around one
quarter of the total showed a partial rescue of the cdKO
phenotype, such that the forebrain vesicle was better organized
and larger in size compared to the cdKO (Figure 7A). Addition-
ally, it appears that there is some improvement in the
morphogenesis of the ventral neuroepithelium in these embryos
(arrowhead, Figure 7A). The other major phenotype, seen in
almost two thirds of Nodal heterozygous cdKO embryos was a
reduction in the forebrain. Nodal
+/z;cdKO embryos with a reduced
forebrain also had a highly disorganized neuroepithelium
(Figure 7A). These results suggest that the HPE phenotype seen
in cdKO embryos can be at least partially rescued by Nodal
heterozygosity, consistent with the defects being due to increased
activity of the Nodal/Smad pathway.
To confirm that the Nodal heterozygous mutation was reducing
expression of Smad2 target genes, we analyzed expression of Fgf8,
which is a direct Smad2/FoxH1 target [53]. As shown earlier, Fgf8
expression is increased in cdKO embryos (Figure 2A), whereas,
Fgf8 expression was significantly reduced in the forebrain of
Nodal
+/z;cdKO embryos, consistent with a reduction in Nodal
signaling to Smad2 (Figure 7B). In order to determine whether
reducing Nodal signaling in cdKO embryos could affect the
output of the Shh signaling pathway, we analyzed the expression
level of Nkx2.1, a target of Shh signaling in the forebrain at
9.0 dpc. Strikingly, Nkx2.1 expression was restored in the ventral
forebrain of Nodal
+/z;cdKO while Nkx2.1 expression was clearly
reduced in cdKO embryos (Figure 7C). Taken together, these
results suggest that Nodal signaling plays a role in regulating Shh
signaling during forebrain development, and that unchecked
Nodal signaling in the absence of Tgifs is responsible, at least
partially, for disrupting Shh signaling in cdKO embryos.
Tgifs coordinate Nodal and Gli3 signaling to regulate
Fgf8 expression
Fgf8 plays a role in coordinating multiple patterning centers
during forebrain development [64,65]. In the telencephalon, Fgf8
Figure 6. Defective separation of facial features. (A) Frontal
forebrain images of stage matched control, cdKO and Gli3
+/r;cdKO
embryos analyzed by in situ hybridization for Pax7. (B) Side and ventral
views of embryos analyzed for Pax2 expression are shown. The Gli3
+/r;
cdKO embryos shown in A and B are representative of 7 and 4
embryos respectively, other images are representative of at least 3.
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by Gli3, a potent inhibitory factor of Shh signaling, during early
forebrain development [24]. Analysis of Fgf8 expression in Shh null
embryos at 8.5 dpc showed that Fgf8 was expressed in the ventral
forebrain (Figure 8A). However, consistent with previous work [64],
Fgf8 expression was reduced in the telencephalon of Shh null
embryos at 8.5 dpc and effectively absent by 9.0 dpc (Figure 8A). In
contrast to the reduction of Fgf8 expression in the Shh null embryos,
the cdKO forebrain at 9.0 dpc showed increased expression of Fgf8,
most likely due to increased Nodal signaling (Figure 2A and
Figure 7B). Interestingly, however, analysis at 9.5 dpc revealed that
Fgf8 expression was not maintained in cdKO embryos, while Fgf8
expressionwasclearlyrestoredinGli3
+/r;cdKOembryos(Figure8B).
This result suggests that, by 9.5 dpc, Fgf8 expression is no longer
maintained byNodal signalingand thatthe excessGli3inthe cdKO
limits Fgf8 expression. We next analyzed the expression pattern of
Foxg1, a target of Fgf8 signaling at 9.5 dpc. Foxg1 expression was
increasedinthecdKO forebrain tissue at9.0 dpc consistent with the
increased expression of Fgf8 (see Figure 2A). At 9.5 dpc, Foxg1
expression in the telencephalon was clearly reduced in the cdKO,
whereas,thelevelofFoxg1expressionwasrestoredtolevelssimilarto
that in controls in Gli3
+/r;cdKO embryos (Figure 8C). Analysis at
10.0 dpc also revealed that Foxg1 expression was reduced in the
neuroepithelium, but was partially restored in Gli3
+/r;cdKO
embryos. The expression of Foxg1 in the optic vesicle was reduced
and was seen as a continuous band in the cdKO (Figure 8C).
Although in Gli3
+/r;cdKO embryos Foxg1 expression was lower than
in controls in the optic vesicle, the expression domains were clearly
better separated than in cdKO embryos, providing further evidence
for a partial rescue of eye field separation (arrowheads, Figure 8C).
Taken together, these results suggest that, at 9.0 dpc Fgf8 expression
is dependent on TGFb/Nodal signaling, whereas, by 9.5 dpc the
effect of TGFb/Nodal signaling decreases and repression of Fgf8 by
Gli3 becomes more pronounced.
Figure 7. Effects of Nodal heterozygosity of the cdKO phenotype. (A) Whole-mount images and H&E stained coronal sections through the
forebrain vesicle of control, cdKO and Nodal
+/z;cdKO embryos at 10.0 dpc are shown. The white lines indicate the plane of coronal sections. Three
Nodal
+/z;cdKO embryos are shown that are representative of the three classes of phenotype seen. The numbers of Nodal
+/z;cdKO embryos analyzed at
10.0 dpc (from a total of 317 embryos) are shown below for each class of phenotype, together with the percentage of the Nodal
+/z;cdKO embryos
with each phenotype: Partial rescue of the HPE phenotype; Reduced forebrain (FB); and severe truncation. Two additional embryos were too severely
delayed to be classified. Note the improved ventral neuroepithelium morphogenesis in the left hand Nodal
+/z;cdKO embryo (arrowhead). The
separation of the facial field by the neuroepithelium in the control is indicated by an arrow. (B) Control, cdKO and Nodal
+/z;cdKO embryos at 9.0 dpc
were analyzed for Fgf8 expression, and for Nkx2.1 expression in (C). Embryos in B and C are representative of at least three each. Scale bars: 250 mm
for whole-mount and 100 mm for sections in A; 250 mm in B and C.
doi:10.1371/journal.pgen.1002524.g007
Tgif and Holoprosencephaly
PLoS Genetics | www.plosgenetics.org 9 February 2012 | Volume 8 | Issue 2 | e1002524Discussion
Of the 12 genetic loci associated with HPE in humans, the best
characterized (SHH, SIX3 and ZIC2) are all linked to the Shh
pathway. In contrast, while mutations in the TGIF1 gene, which
encodes a corepressor for TGFb/Nodal signaling, are associated
with HPE pathogenesis, the underlying role of Tgif function in
forebrain development has remained unclear. We now demon-
strate that all embryos with a conditional epiblast-specific double
knock-out of Tgif1 and Tgif2 exhibit early HPE-like phenotypes
that are reminiscent of those seen in Shh null embryos. Our results
provide strong evidence that a major function of Tgifs in the
forebrain is to maintain the proper balance between Shh and its
antagonist, Gli3, by limiting Nodal signaling. These results resolve
the conundrum of how Tgif function is associated with HPE, and
identify novel points of coordination between the Shh, Nodal and
FGF signaling pathways during anterior development (Figure 9).
SHH, SIX3, ZIC2 and TGIF1, are the four genes that are most
commonly screened as a part of the genetic evaluation of human
HPE patients [66]. Mice homozygous for a Shh null allele exhibit
defects in midline facial features including cyclopia and proboscis
that are typically seen in severe cases of human HPE, suggesting
that SHH mutations do contribute to HPE in humans [50]. Recent
work showed that the transcription factor Six3 is directly linked to
Shh signaling by acting as a transcriptional activator of the Shh
gene, specifically in the ventral forebrain [21,22]. ZIC2, encodes a
zinc-finger containing transcription factor, that has been shown to
be important for forebrain patterning and Shh signaling [67,68].
Thus, the best characterized HPE mutations appear to target the
Shh signaling pathway. In contrast, the role in HPE pathogenesis
of mutations in TGIF1, which encodes a corepressor for TGFb/
Nodal signaling, has long remained unclear. Loss of function
mutations in the Tgif1 gene in mice have no severe phenotypes in a
mixed strain background, although an intragenic mutation in
Tgif1, which may create a hypomorphic allele, has been shown to
cause anterior defects in a strain specific manner [47]. However,
HPE phenotypes have not been seen in Tgif1 or Tgif2 mutants, and
these analyses have not yet shed light on any potential role in HPE
pathogenesis.
Tgif2, a closely related Tgif1 paralog present in mouse and
human, shares conserved functions with Tgif1 [69]. Both Tgif1
and Tgif2 show ubiquitous expression in the embryo proper from
at least 6.0 dpc, consistent with the possibility of overlapping
function during early development. As with Tgif1 mutations, mice
that carry a homozygous Tgif2 mutation do not show appreciable
Figure 8. Analysis of Fgf8 expression. (A) Control and Shh null embryos were analyzed for Fgf8 expression at 8.5 and 9.0 dpc. (B) Control, cdKO
and Gli3
+/r;cdKO embryos were analyzed for Fgf8 expression at 9.5 dpc, and in (C) for Foxg1 expression at 9.5 and 10.0 dpc. Embryos are
representative of at least three of each genotype at each stage and 5 each for panel B. Arrows indicate the eye field expression of Foxg1, and show
the partial rescue of eye field separation in the Gli3
+/r;cdKO embryo (arrowheads). Scale bar: 180 mm at 8.5 dpc and 250 mm at 9.0 dpc in A; 250 mmi n
B, C and D.
doi:10.1371/journal.pgen.1002524.g008
Figure 9. Model for the role of Tgifs in signaling during
forebrain development. A tentative model is shown that describes
the data presented here. Briefly, Tgifs limit Smad2 transcriptional
activity, which is required for activation of Fgf8 expression. Tgif
regulation of the Nodal-Smad2 pathway is required for the correct
balance between Gli3 and Shh activity in the Shh pathway. Dashed lines
indicate that the links from the Nodal-Smad2 pathway to Shh signaling
components may not be direct, and that the regulation may be of both
Shh and Gli3, or may occur primarily via one of them.
doi:10.1371/journal.pgen.1002524.g009
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and Tgif2 mutations, with at least one wild-type allele of either
Tgif1 or Tgif2, are also viable and fertile in a mixed strain
background [48]. In contrast, embryos with homozygous mutation
of both Tgif1 and Tgif2 fail to gastrulate, providing strong evidence
that Tgif1 and Tgif2 perform essential overlapping functions
during embryogenesis. Thus, although there is no evidence
suggesting that human TGIF2 is associated with HPE [42], it is
possible at least in mice, that both proteins share overlapping
functions in anterior development. We generated embryos with
Sox2-Cre mediated conditional deletion of Tgif1 in the background
of a Tgif2 null, which allows the resulting embryos to undergo
gastrulation successfully. At 10.0 dpc, the cdKO embryos have an
HPE-like forebrain and neuroepithelium morphology, and the
expression patterns of Pax2 and Pax7 suggest that separation of
midline facial features is defective. Moreover, SEM analysis shows
that separation of the ventral lips of the cephalic neural fold is
defective, consistent with the failure to divide midline facial
features. These phenotypes are typical of early HPE mouse
mutants such as Shh null embryos, clearly demonstrating that Tgif1
and Tgif2 share redundant functions and together are essential
players in normal forebrain development. Although the majority
of cdKO embryos fail to survive past 11.0 dpc, from an analysis of
117 embryos where approximately 30 were expected to be cdKO,
we were able to identify two embryos lacking both Tgif1 and Tgif2
at 12.5 dpc, which had presumably survived to this point due to a
slight delay in recombination of the conditional Tgif1 allele.
Interestingly, these two embryos also showed remarkable similarity
to Shh null embryos at the same stage. Specifically, one had a
proboscis and both had cyclopia, further reinforcing the idea that
the early phenotypes analyzed in detail here are clear precursors of
later HPE. While the fact that relatively few embryos survive past
11.0 dpc limits our ability to analyze later HPE phenotypes in
detail, those cdKO embryos that do survive to 12.5 dpc have
classic HPE phenotypes. Despite the similarity of the HPE-like
phenotypes, it should be noted that there are some differences
between our cdKO and Shh null embryos. Such differences include
the failure of the midbrain neural tube to close, which is not seen
in Shh nulls, and the fact that the majority of cdKO embryos die by
11.0 dpc, whereas most Shh null embryos survive to late gestation.
These differences aside, this work provides the first clear evidence
from mouse models for a role for loss of Tgif function in HPE
pathogenesis.
Our data suggest that Tgif function is required for appropriate
Shh signaling during forebrain development. In cdKO embryos,
Shh expression is present but reduced in the PrCP, and is
undetectable in the neuroepithelium, suggesting that Shh is
transcriptionally activated but that its expression is not properly
maintained. In addition to the defective Shh expression in the
forebrain, the expression of downstream targets of Shh signaling is
significantly reduced in the forebrain. Expression of Gli3, which
encodes a repressor for the Shh signaling pathway in the forebrain,
is up-regulated in Shh null embryos, and the HPE phenotype of Shh
null embryos is partially rescued when the genetic dose of Gli3 is
reduced [27,61]. Similarly, cdKO embryos showed an increased
level of Gli3 expression in the forebrain. Intriguingly, the increase
in Gli3 expression in cdKO was clearly higher than in Shh null
embryos, suggesting that there is an additional, Shh-independent,
Tgif-dependent mechanism that regulates Gli3 gene expression. In
cdKO embryos with a reduced dose of Gli3, there was a
phenotypic rescue in the morphology of the forebrain neuroep-
ithelium and also of the craniofacial features. Additionally, Nkx2.1
expression was restored in the ventral diencephalon of cdKO
embryos carrying a Gli3 heterozygous mutation, while, in
agreement with previous work, there was no rescue of Nkx2.1
expression in the diencephalon of Shh null embryos with a Gli3
heterozygous mutation [61]. This suggests that some level of Shh
expression is required for Nkx2.1 expression, and also suggests that
sufficient Shh expression is present to activate Nkx2.1 in the ventral
diencephalon of cdKO embryos. However, it should be noted that
Shh expression was not rescued in the ventral forebrain of Gli3
mutant cdKO embryos. Although many mutations that cause
HPE may do so by affecting the Shh pathway, and specifically the
balance between Shh and Gli3, it is worth pointing out that Gli3
heterozygosity does not rescue all mouse models of HPE. For
example, the phenotype of Fgfr1;Fgfr2 double mutant embryos is
not rescued by Gli3 mutation, suggesting that there is some
specificity to the rescue by Gli3 mutations [29]. Taken together,
these data provide strong evidence that Tgifs play a critical role in
regulating Shh signaling during forebrain development, and that
the loss of Tgif-mediated regulation of the Shh pathway is
important for HPE pathogenesis.
Studies in humans and mice have implicated both the retinoic
acid and TGFb/Nodal pathways in HPE pathogenesis. Retinoic
acid mediated teratogenesis in humans is known to contribute to
CNS anomalies such as hydrocephalus, and in a few rare cases,
HPE, and in mice in utero administration of retinoic acid to
pregnant females on gestational day 7 leads to embryos with
severe craniofacial phenotypes including HPE [70,71]. However,
mutations in genes associated with retinoic acid signaling have
not been identified in HPE patients. Mutations that likely reduce
the output of the TGFb/Nodal pathway have been found in
human patients with HPE or laterality defects. Mutations in
TDGF1 (also referred to as CRIPTO), an EGF-CFC family
member that acts as a co-factor for the NODAL ligand, and in
the gene encoding the forkhead transcription factor FOXH1 (also
known as FAST1), which complexes with SMAD2 and SMAD4
to mediate TGFb/NODAL signaling, have been identified
[72,73]. However, these mutations are found very rarely in
HPE, and in general are not complete loss of function alleles.
Studies in Tdgf1 null and Foxh1 null embryos show that these
genes are required for the activity of the early organizing centers
during gastrulation [74,75]. In Tdgf1 null embryos, marker
analysis shows that expression of organizer genes including
Brachyury, Cerl1 and Lhx1 is defective. Similarly in Foxh1 null
embryos, expression of organizer genes such as Foxa2 and
Goosecoid, is reduced, and analysis of forebrain markers such as
Six3, Hesx1 and Fgf8 shows that the forebrain tissue is significantly
reduced, exhibiting a mild anterior truncation phenotype [75]. It
has also been suggested that Nodal;Smad2 double heterozygous
mutations can result in HPE, again indicating that a reduction in
TGFb/Nodal signaling is important in HPE pathogenesis [1].
However, the morphology of these embryos suggests that in most
cases forebrain tissue is reduced or missing, rather than exhibiting
a clear HPE phenotype as seen in Shh null embryos, for example.
Thus it appears that, at least in mice, a reduction in the TGFb/
Nodal signaling pathway primarily results in defective early
organizing centers, leading to phenotypes such as a small or
truncated forebrain. In contrast, in our cdKO embryos, marker
analysis shows that the organizing centers are formed, and that
the forebrain does not show an anterior truncation phenotype. In
addition, the forebrain morphology shows an HPE phenotype
that is similar in many respects to that seen in Shh null embryos,
and forebrain markers show relatively normal expression
patterns, suggesting that the forebrain is reasonably formed in
cdKO embryos. Our own analysis of embryos that are
heterozygous for both Smad2 and Nodal is in agreement with the
idea that HPE is relatively rare in this genetic combination – only
Tgif and Holoprosencephaly
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had HPE, with an additional 15 showing severe growth delays or
anterior truncations. Additionally, it is interesting to note that the
comparison of cdKO, Shh null and Smad2/Nodal double
heterozygous embryos with HPE at 12.5 dpc suggests that, at
least superficially, the Shh null and cdKO are more similar to
each other than to the Smad2/Nodal double heterozygote. Thus
the loss of Tgif1 and Tgif2 causes a classic HPE phenotype, rather
than the predominance of anterior truncations that are seen in
embryos with reduced activity of the TGFb/Nodal pathway.
Our results, together with evidence from mouse mutants with
reduced Nodal activity, support a model in which decreased
Nodal signaling primarily results in a truncation of anterior
tissues, whereas increased Nodal signaling (as in our cdKO
embryos) causes classic HPE phenotypes. One alternate inter-
pretation of this difference between the HPE phenotype in cdKO
embryos and other TGFb/Nodal mouse mutants is that the
effects of loss of Tgif function are independent of TGFb/Nodal
signaling during forebrain development. However, we have
shown that embryos that are homozygous null for both Tgif1
and Tgif2 fail gastrulation, and that the gastrulation defect is
dependent on increased TGFb/Nodal signaling. Similarly, left-
right asymmetry defects in cdKO embryos can be partially
rescued by reducing the dose of Nodal [48]. Here we show that at
9.0 dpc, Fgf8 expression is increased in the cdKO, consistent with
the derepression of a Smad/Foxh1 target gene [53]. Importantly,
this excess Fgf8 expression is reduced in the Nodal heterozygote.
Reducing the dose of Nodal also results in a partial rescue of the
HPE phenotypes in a proportion of cdKO embryos. Most of the
remaining Nodal heterozygous cdKO embryos have a mild
anterior truncation, which might indicate that there are
additional Nodal and Tgif specific phenotypes, but could also
reflect the effect of mutating multiple components of the Nodal
pathway. However, with the restoration of Nkx2.1 expression in
the Nodal heterozygous cdKO forebrain, this is clearly consistent
with a model in which Tgifs limit Nodal signaling and that the
absence of this restraint causes disruption of the Shh pathway and
HPE. It should, however, be noted that we have not yet
exhaustively analyzed the Shh signaling pathway in Nodal
heterozygous cdKO embryos, and it will clearly be of interest
in the future to determine precisely how Nodal heterozygosity
rescues Nkx2.1 expression and forebrain morphology. One
attractive candidate for the Nodal target would be the Gli3 gene,
given its striking upregulation in the cdKO. However, this
remains to be tested and potential effects of other pathways, such
as FGF signaling, that specify forebrain patterning should also be
considered. On balance, it is reasonable at this point to suggest
that the HPE phenotype seen in cdKO embryos is dependent on
excessive TGFb/Nodal signaling due to the loss of Tgif-mediated
repression, and that disruption of the Shh pathway makes a
major contribution to the phenotype.
The increased Fgf8 expression seen at 9.0 dpc in cdKO
embryos is consistent with an increase in Nodal signaling, and is
in fact reduced in the Nodal heterozygote. However, this also
appears to be somewhat at odds with the increased Gli3
expression seen in cdKO embryos, since Gli3 represses Fgf8
expression in the anterior. However, by 9.5 dpc, we show that
Fgf8 expression in the cdKO telencephalon is essentially lost,
consistent with increased repression by Gli3. It is likely that by
this stage the effect of Nodal signaling is diminishing, even in the
cdKO, and so the excess Gli3 predominates. In support of this,
Gli3 heterozygosity restores some Fgf8 expression and restores
expression of Foxg1, which is a downstream target of FGF signals
in the anterior [65]. Analysis of Fgf8 expression in Shh null
embryos reveals that expression is already lost by 9.0 dpc, while
at this stage in the cdKO it is increased. However, as with the
Gli3 heterozygous cdKO at 9.5 dpc, the loss of Fgf8 expression in
Shh null embryos can be rescued by Gli3 heterozygosity [24,61].
Thus the loss of Fgf8 expression in the anterior may contribute to
the HPE phenotypes seen in both Shh null and cdKO embryos,
and the difference in timing of the loss of expression may also be
in part responsible for some of the differences between these two
models. Given that loss of Fgf8 expression is common to the Shh
null and cdKO HPE models, it is tempting to speculate that in
the small proportion of Smad2/Nodal double heterozygous
mutants with the HPE phenotype is in part due to a failure to
fully activate Fgf8 expression.
Taken together, our data suggest a model in which Tgifs limit
the activity of the Nodal-Smad2 pathway, which is required for full
activation of Smad/Foxh1 targets, such as Fgf8 (Figure 9). In
addition we provide evidence that regulation of Nodal signaling by
Tgifs is required to maintain the appropriate balance between Shh
and Gli3 levels in the forebrain. However, it should be noted that
we do not yet know whether this occurs via direct regulation of
Gli3 or Shh expression (dashed lines in Figure 9), or whether the
regulation is less direct. An additional possibility is that at least
some of the regulation of the Shh pathway by Tgifs is independent
of Nodal/Smad2. For example, Gli3 might be a direct target of
Tgif repression, although the rescue of Nkx2.1 expression in the
Nodal heterozygotes is consistent with a Nodal dependent
regulation of the Shh pathway. In summary, this work provides
the first clear evidence for a role for loss of Tgif function in HPE
pathogenesis, and suggests that Tgifs regulate Shh signaling
pathway activity. We propose that Tgif function limits Gli3
expression, and that by a mechanism that is independent of
changes in Gli3 levels, Tgifs are required for full Shh expression in
the PrCP and neuroepithelium. Thus, the Tgifs have significant
contributions to HPE pathogenesis by functioning as key
regulators of Shh signaling during forebrain development, most
likely by limiting Nodal signaling.
Materials and Methods
Ethics statement
All animal procedures were approved by the Animal Care and
Use Committee of the University of Virginia, which is fully
accredited by the AAALAC.
Mice and DNA analysis
The loxP flanked Tgif allele [45], Tgif2 null [48], loxP flanked Gli3
allele [62], Nodal mutants [76], loxP flanked Smad2 allele [77], and
the Sox2-Cre line [49] have been described previously. Conditional
Shh mice were obtained from Jackson labs (stock 4293; [78]). The
Gli3, Shh and Smad2 alleles each contain loxP flanked exons, which
when recombined result in null alleles, and are referred to here as
‘r’ for recombined (null). The Nodal null allele is referred to as ‘z’,
for an introduced lacZ reporter. All mouse lines were maintained
on a mixed C57BL/6J6129Sv/J background. Genomic DNA for
PCR genotype analysis was purified from ear punch, at post-natal
day 21 (P21), or yolk sac (7.0–10.0 dpc) by HotShot [79].
In situ hybridization
Whole-mount in situ hybridization was performed on 7.5–
10.0 dpc embryos with digoxigenin-labeled riboprobes, as de-
scribed [80]. Stained embryos were processed for sectioning and
histology as described [58]. All images are representative of at least
three embryos analyzed.
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mount analysis
Embryos were fixed overnight in 4% paraformaldehyde at 4uC,
dehydrated through an ethanol series (70%, 90%, 95%, 100%62
for 30 minutes each), incubated in xylene twice for 60 minutes and
1:1 xylene/paraffin for 60 minutes at 60uC, then embedded in
paraffin wax, and sectioned at 7 mm. For Hematoxylin and Eosin
(H&E) histological analysis, sections were de-paraffinized with
xylene and stained with H&E. Multiple sections per embryo were
incubated with primary antibodies for pHH3 or active caspase 3 as
described [48]. For IHC, antibody staining was detected using
Vectastain ABC (Vector Laboratories) and developed with Impact
DAB (Vector Laboratories). For H&E and IHC images were
captured using an Olympus BX51 microscope and either an
Olympus SZX12 or DP70 digital camera, and manipulated in
Adobe Photoshop. Images of 7.0–10.0 dpc embryos were captured
using a Leica MZ16 stereomicroscope and QImaging 5.0 RTV
digital camera.
Scanning electron microscopy
Embryos were fixed overnight in 4% paraformaldehyde at 4uC,
and then fixed with osmium tetraoxide for 30 min and dehydrated
through an ethanol series (40%, 60%, 80% and 100% 62 for
15 minutes each). Dehydrated samples were further processed in
an Autosamdri-815 (Tousimis Research Corporation) and were
gold coated by using a SCD005 Sputter Coater (Bal-Tec). Images
were captured using a JSM-6400 Scanning Electron Microscope
(JEOL).
Supporting Information
Figure S1 Comparison of a Nodal;Smad2 double heterozygous
embryo with HPE to Shh null and cdKO embryos. Whole mount
images and H&E stained sections of fixed and paraffin-embedded
control, cdKO and Shh null embryos at 12.5 dpc are shown (note
these are the same images as in Figure 1E). Additionally, similar
images of a Nodal;Smad2 double heterozygote are shown to the
right. The two planes of section are indicated in the upper panels,
and a magnified view of the eye is shown at the bottom. Note that
the eyes in the Nodal;Smad2 double heterozygote have formed and
begun to separate, whereas the Shh null and cdKO have a single
eye rudiment. The Nodal;Smad2 double heterozygote was the only
embryo with HPE from 41 of this genotype examined at 10.5–
12.5 dpc. Scale bar: 2 mm for whole-mount; 250 mm for i,
500 mm for ii and 100 mm for ii-zoom. In the lower panels, the eye
in the control embryo is bracketed, the single eye fields in the
cdKO and Shh null are circled, and the partial separation between
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